Redmile Group, Llc - Net Worth and Insider Trading

Redmile Group, Llc Net Worth

The estimated net worth of Redmile Group, Llc is at least $980 Million dollars as of 2025-05-09. Redmile Group, Llc is the 10% Owner of Array BioPharma Inc and owns about 16,658,072 shares of Array BioPharma Inc (ARRY) stock worth over $649 Million. Redmile Group, Llc is the 10% Owner of Amicus Therapeutics Inc and owns about 12,956,446 shares of Amicus Therapeutics Inc (FOLD) stock worth over $78 Million. Redmile Group, Llc is also the 10% Owner of Zymeworks Inc and owns about 6,075,918 shares of Zymeworks Inc (ZYME) stock worth over $69 Million. Besides these, Redmile Group, Llc also holds Augmedix Inc (AUGX) , ADC Therapeutics SA (ADCT) , Absci Corp (ABSI) , Entrada Therapeutics Inc (TRDA) , Xeris Biopharma Holdings Inc (XERS) , Fate Therapeutics Inc (FATE) , Verve Therapeutics Inc (VERV) , Shattuck Labs Inc (STTK) , IGM Biosciences Inc (IGMS) , Invivyd Inc (IVVD) , Neoleukin Therapeutics Inc (NLTX) , Aprea Therapeutics Inc (APRE) , Syros Pharmaceuticals Inc (SYRS) . Details can be seen in Redmile Group, Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Redmile Group, Llc has not made any transactions after 2024-12-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Redmile Group, Llc

To

Redmile Group, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Redmile Group, Llc owns 35 companies in total, including Shattuck Labs Inc (STTK) , IGM Biosciences Inc (IGMS) , and Kymera Therapeutics Inc (KYMR) among others .

Click here to see the complete history of Redmile Group, Llc’s form 4 insider trades.

Insider Ownership Summary of Redmile Group, Llc

Ticker Company Transaction Date Type of Owner
STTK Shattuck Labs Inc 2024-12-04 director & 10 percent owner
IGMS IGM Biosciences Inc 2023-06-29 director & 10 percent owner
KYMR Kymera Therapeutics Inc 2020-08-20 10 percent owner
LIMIT LIMIT 2020-07-29 10 percent owner
LIMIT LIMIT 2020-07-23 10 percent owner
LIMIT LIMIT 2020-07-23 10 percent owner
LIMIT LIMIT 2020-06-18 10 percent owner
LIMIT LIMIT 2024-12-20 director & 10 percent owner
LIMIT LIMIT 2020-06-02 10 percent owner
LIMIT LIMIT 2020-04-02 10 percent owner
LIMIT LIMIT 2020-02-05 10 percent owner
LIMIT LIMIT 2019-10-24 10 percent owner
LIMIT LIMIT 2019-10-22 director
LIMIT LIMIT 2020-12-28 10 percent owner
LIMIT LIMIT 2019-06-19 10 percent owner
LIMIT LIMIT 2019-06-19 10 percent owner
LIMIT LIMIT 2019-06-18 10 percent owner
LIMIT LIMIT 2019-04-17 10 percent owner
LIMIT LIMIT 2019-02-19 10 percent owner
LIMIT LIMIT 2019-02-13 10 percent owner
LIMIT LIMIT 2018-11-13 10 percent owner
LIMIT LIMIT 2018-09-27 10 percent owner
LIMIT LIMIT 2018-07-19 10 percent owner
LIMIT LIMIT 2018-07-18 10 percent owner
LIMIT LIMIT 2016-07-06 10 percent owner
LIMIT LIMIT 2016-06-03 10 percent owner
LIMIT LIMIT 2020-11-17 director & 10 percent owner
LIMIT LIMIT 2024-03-01 director & 10 percent owner
LIMIT LIMIT 2021-11-02 10 percent owner
LIMIT LIMIT 2023-11-20 director & 10 percent owner
LIMIT LIMIT 2021-10-06 director & 10 percent owner
LIMIT LIMIT 2021-08-10 10 percent owner
LIMIT LIMIT 2021-06-21 10 percent owner
LIMIT LIMIT 2022-10-13 10 percent owner
LIMIT LIMIT 2023-09-14 10 percent owner

Redmile Group, Llc Latest Holdings Summary

Redmile Group, Llc currently owns a total of 16 stocks. Among these stocks, Redmile Group, Llc owns 16,658,072 shares of Array BioPharma Inc (ARRY) as of September 28, 2016, with a value of $649 Million and a weighting of 66.2%. Redmile Group, Llc owns 12,956,446 shares of Amicus Therapeutics Inc (FOLD) as of June 3, 2016, with a value of $78 Million and a weighting of 7.91%. Redmile Group, Llc also owns 6,075,918 shares of Zymeworks Inc (ZYME) as of October 13, 2022, with a value of $69 Million and a weighting of 7.04%. The other 13 stocks Augmedix Inc (AUGX) , ADC Therapeutics SA (ADCT) , Absci Corp (ABSI) , Entrada Therapeutics Inc (TRDA) , Xeris Biopharma Holdings Inc (XERS) , Fate Therapeutics Inc (FATE) , Verve Therapeutics Inc (VERV) , Shattuck Labs Inc (STTK) , IGM Biosciences Inc (IGMS) , Invivyd Inc (IVVD) , Neoleukin Therapeutics Inc (NLTX) , Aprea Therapeutics Inc (APRE) , Syros Pharmaceuticals Inc (SYRS) have a combined weighting of 18.85% among all his current holdings.

Latest Holdings of Redmile Group, Llc

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ARRY Array BioPharma Inc 2016-09-28 16,658,072 38.95 648,831,904
FOLD Amicus Therapeutics Inc 2016-06-03 12,956,446 5.99 77,544,329
ZYME Zymeworks Inc 2022-10-13 6,075,918 11.36 69,022,428
AUGX Augmedix Inc 2023-11-20 25,850,163 2.35 60,747,883
ADCT ADC Therapeutics SA 2024-12-11 28,812,443 1.28 36,735,865
ABSI Absci Corp 2024-03-01 8,253,316 2.74 22,572,819
TRDA Entrada Therapeutics Inc 2021-11-02 1,954,420 8.36 16,338,951
XERS Xeris Biopharma Holdings Inc 2019-02-19 3,000,642 5.04 15,108,232
FATE Fate Therapeutics Inc 2024-12-20 12,884,277 1.04 13,399,648
VERV Verve Therapeutics Inc 2021-06-21 1,936,530 4.21 8,143,109
STTK Shattuck Labs Inc 2024-12-04 5,539,724 0.96 5,332,538
IGMS IGM Biosciences Inc 2023-06-29 2,974,186 1.13 3,360,830
IVVD Invivyd Inc 2021-08-10 3,390,960 0.63 2,144,782
NLTX Neoleukin Therapeutics Inc 2020-04-02 202,061 3.49 705,193
APRE Aprea Therapeutics Inc 2020-12-28 88,436 1.64 145,035
SYRS Syros Pharmaceuticals Inc 2016-07-06 4,979 0.03 151

Holding Weightings of Redmile Group, Llc


Redmile Group, Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Redmile Group, Llc has made a total of 0 transactions in Array BioPharma Inc (ARRY) over the past 5 years. The most-recent trade in Array BioPharma Inc is the sale of 2,492,578 shares on September 28, 2016, which brought Redmile Group, Llc around $16 Million.

According to the SEC Form 4 filings, Redmile Group, Llc has made a total of 0 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years. The most-recent trade in Amicus Therapeutics Inc is the acquisition of 66,300 shares on June 3, 2016, which cost Redmile Group, Llc around $477,360.

According to the SEC Form 4 filings, Redmile Group, Llc has made a total of 1 transactions in Zymeworks Inc (ZYME) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Zymeworks Inc is the acquisition of 30,481 shares on October 13, 2022, which cost Redmile Group, Llc around $153,319.

More details on Redmile Group, Llc's insider transactions can be found in the Insider Trading History of Redmile Group, Llc table.

Insider Trading History of Redmile Group, Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Redmile Group, Llc Trading Performance

GuruFocus tracks the stock performance after each of Redmile Group, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Redmile Group, Llc is 6.29%. GuruFocus also compares Redmile Group, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Redmile Group, Llc within 3 months outperforms 13 times out of 40 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Redmile Group, Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Redmile Group, Llc

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
17 out of 35 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.17 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 6.93 LIMIT LIMIT LIMIT LIMIT LIMIT

Redmile Group, Llc Ownership Network

Ownership Network List of Redmile Group, Llc

No Data

Ownership Network Relation of Redmile Group, Llc

Insider Network Chart


Redmile Group, Llc Owned Company Details

What does Shattuck Labs Inc do?

Who are the key executives at Shattuck Labs Inc?

Redmile Group, Llc is the director & 10 percent owner of Shattuck Labs Inc. Other key executives at Shattuck Labs Inc include director & Chief Executive Officer Taylor Schreiber , See Remarks Stephen Stout , and See Remarks Andrew R Neill .

Shattuck Labs Inc (STTK) Insider Trades Summary

Over the past 18 months, Redmile Group, Llc made 2 insider transaction in Shattuck Labs Inc (STTK) with a net sale of 0. Other recent insider transactions involving Shattuck Labs Inc (STTK) include a net purchase of 50,900 shares made by Taylor Schreiber , a net sale of 25,000 shares made by Andrew R Neill , and a net sale of 16,004 shares made by Stephen Stout .

In summary, during the past 3 months, insiders sold 0 shares of Shattuck Labs Inc (STTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 174,375 shares of Shattuck Labs Inc (STTK) were sold and 192,687 shares were bought by its insiders, resulting in a net purchase of 18,312 shares.

Shattuck Labs Inc (STTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Shattuck Labs Inc Insider Transactions

No Available Data

Redmile Group, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Redmile Group, Llc. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Redmile Group, Llc's mailing address is: San Francisco Ca 94129.